Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Vaccinex, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +3 vs. Q3 2022
- Shares held
- 4.69M
- +74.5K (+1.6%) vs. Q3 2022
- Total value
- $3.12M
- +$833.5K (+36.5%) vs. Q3 2022
- New holders
- 5
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 300 | $0 | 0.00% | +300 | New |
| Bank of America Corp | 54 | $34 | 0.00% | +54 | New |
| Money Concepts Capital Corp | 110 | $71 | 0.00% | +110 | New |
| Wells Fargo & Company | 189 | $122 | 0.00% | +5+2.7% | Added |
| Cornerstone Planning Group LLC | 200 | $122 | 0.00% | +200 | New |
| Morgan Stanley | 300 | $193 | 0.00% | −64−17.6% | Reduced |
| UBS Group AG | 2,151 | $1.38K | 0.00% | +2,151 | New |
| Advisor Group Holdings, Inc. | 3,500 | $2.00K | 0.00% | −100−2.8% | Reduced |
| Royal Bank of Canada | 5,153 | $3.00K | 0.00% | −266−4.9% | Reduced |
| Citadel Advisors LLC | 7,588 | $5.00K | 0.00% | −92,680−92.4% | Reduced |
| Vectors Research Management, LLC | 10,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Moors & Cabot, Inc. | 10,000 | $6.45K | 0.00% | 00.0% | Unchanged |
| HNP Capital LLC | 10,000 | $6.45K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 11,000 | $7.09K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 20,971 | $13.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 23,369 | $15.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 37,964 | $25.0K | 0.00% | −32,847−46.4% | Reduced |
| BlackRock Inc. | 50,589 | $32.6K | 0.00% | +1,072+2.2% | Added |
| Simplex Trading, LLC | 65,174 | $42.0K | 0.00% | −1,370−2.1% | Reduced |
| State Street Corp | 71,400 | $47.1K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 250,186 | $164.0K | 0.00% | −694−0.3% | Reduced |
| Telemetry Investments, L.L.C. | 416,000 | $268.0K | 0.63% | −74,000−15.1% | Reduced |
| Worth Venture Partners, LLC | 507,795 | $334.6K | 0.20% | 00.0% | Unchanged |
| Vanguard Group Inc | 732,859 | $472.3K | 0.00% | +694+0.1% | Added |
| AIGH Capital Management LLC | 2,451,801 | $1.66M | 0.55% | +370,000+17.8% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −87,700−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,370−100.0% | Sold out |